Associate professor
Max Rady College of Medicine
Medical Microbiology and Infectious Diseases
Room 512 – 745 Bannatyne Ave.
University of Manitoba
Winnipeg, Manitoba R3E 0J9
zulma.rueda@umanitoba.ca
Fax: 204-789-3926
The University of Manitoba campuses are located on original lands of Anishinaabeg, Ininew, Anisininew, Dakota and Dene peoples, and on the National Homeland of the Red River Métis. More
University of Manitoba
Winnipeg, Manitoba Canada, R3T 2N2
Max Rady College of Medicine
Medical Microbiology and Infectious Diseases
Room 512 – 745 Bannatyne Ave.
University of Manitoba
Winnipeg, Manitoba R3E 0J9
zulma.rueda@umanitoba.ca
Fax: 204-789-3926
Dr. Zulma Rueda is a Canada Research Chair in Sexually Transmitted Infection – Resistance and Control and leads the Exposome Lab at the University of Manitoba. She is also a clinician-epidemiologist and has adapted statistical tools to answer complex questions in the fields of tuberculosis (TB) and HIV research. She has developed and tested new statistical approaches to handle complex biological data, optimized data pretreatment prior to multivariate analysis, and applied new statistical methods to understand the exposome in TB and HIV.
Her research focuses on identifying biomarkers for latent tuberculosis diagnosis, understanding the interaction between HIV and TB, and identifying the factors that contribute to the spread of tuberculosis in prison populations. Dr. Rueda's research group has already identified HLA alleles associated with disease progression of HIV and immune markers predicting poor immune response to antiretroviral therapy. She has also identified the risk factors associated with TB acquisition in prisons and the paths of transmission to the community.
Dr. Rueda has published 49 papers and six book chapters, with 42 peer-reviewed research contributions, including eight first authorships and seven senior authorships where her students appear as first authors. She participates as a scientific reviewer for 10 scientific journals and has received several project grants as a principal investigator and co-investigator, totaling approximately $4.2 million CAD.
Dr. Rueda has contributed to international and public health research by serving as a senior mentor for a global partnership by the Special Programme for Operational Research Training in HIV and TB (TDR) at the World Health Organization.
Biomarkers
Disease acquisition and progression
Epidemiology
Exposome
HIV/Aids
Latent tuberculosis infection
Sexually transmitted and blood borne infections
Tuberculosis
Exposome Lab, University of Manitoba
Public Health Research Group, Universidad Pontificia Bolivariana (Colombia)
Dr. Zulma Rueda is an associate professor in medical microbiology and infectious diseases at the Max Rady College of Medicine at the University of Manitoba. Dr. Rueda is also a Canada Research Chair in Sexually Transmitted Infection – Resistance and Control, and leads the Exposome Lab at the University of Manitoba.
Dr. Rueda obtained her medical degree from the Universidad de Antioquia in Colombia in 2006, and went on to complete a PhD in epidemiology at the same institution in 2014, earning the highest distinction for her thesis. Her doctoral work focused on identifying the factors that contribute to the spread of tuberculosis (TB) in prison populations, and she was recognized with a Distinguished Service Special Category award by the National Penitentiary and Prison Institute for her contributions to the health of prisoners in Antioquia, Colombia.
Dr. Rueda has since become a clinician-epidemiologist and innovator, and has adapted statistical tools to answer complex questions in the fields of TB and HIV research. She has developed and tested new statistical approaches to handle complex biological data, optimized data pretreatment prior to multivariate analysis, and applied new statistical methods to understand the exposome (i.e., the genetic and non-genetic exposure data) in TB and HIV. Her research focuses on identifying biomarkers for latent TB diagnosis, and understanding the interaction between HIV and TB.
Dr. Rueda's research group has already identified HLA alleles associated with disease progression of HIV and immune markers predicting poor immune response to antiretroviral therapy. She has also identified the risk factors associated with TB acquisition in prisons and the paths of transmission to the community. Dr. Rueda has published 49 papers and six book chapters, with 42 peer-reviewed research contributions, including eight first authorships and seven senior authorships where her students appear as first authors.
Dr. Rueda has contributed to international and public health research by serving as a senior mentor for a global partnership by the Special Programme for Operational Research Training in HIV and TB (TDR) at the World Health Organization. She has been invited to teach and mentor employees of TB and/or HIV care programs in Panama, Colombia, Ecuador, Iraq, and China. Dr. Rueda was also elected as a member of the Colombian Public Entity (INVIMA), which is the equivalent of the US Food and Drug Administration (FDA).
In recognition of her contributions to the field of infectious diseases, Dr. Rueda has received numerous awards and scholarships, including the Canada Research Chair Tier 2 award in 2020, and the Summa cum laude "with highest praise" for her PhD thesis, awarded to approximate to top 1% based on set of criteria, most importantly potential contribution to health. She was also named the Best Student of Medicine at the Universidad de Antioquia, Faculty of Medicine in Colombia in 2005.
PhD in Epidemiology (highest distinction for a PhD thesis), Universidad de Antioquia, Colombia (2014)
Physician, Universidad de Antioquia, Colombia (2006)
2020:
2014:
2009:
2008:
2005:
Rady Faculty of Health Sciences
Rady Faculty of Health Sciences, Research and International, Students
Rady Faculty of Health Sciences
Medical Microbiology and Infectious Diseases
Max Rady College of Medicine
Room 543 - 745 Bannatyne Avenue
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0J9 Canada